NORDIC LABORATORIES ApS — Credit Rating and Financial Key Figures
CVR number: 26672953
Nygade 6, 1164 København K
cm@nordic-labs.com
tel: 33751009
Income statement (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 6 730.47 | 7 642.60 | 8 992.97 | 7 326.12 | 6 814.09 |
| Employee benefit expenses | -4 146.14 | -4 597.61 | -5 864.81 | -6 890.25 | -6 703.45 |
| Total depreciation | - 400.41 | - 696.98 | - 741.57 | - 393.59 | -28.57 |
| EBIT | 2 183.92 | 2 348.01 | 2 386.59 | 42.28 | 82.08 |
| Other financial income | 36.97 | 14.66 | 535.85 | 52.21 | 204.12 |
| Other financial expenses | -82.18 | - 178.69 | -38.93 | -27.45 | -9.88 |
| Net income from associates (fin.) | -18.75 | - 814.35 | 369.87 | ||
| Pre-tax profit | 2 119.97 | 2 183.98 | 2 883.50 | - 747.30 | 646.19 |
| Income taxes | - 477.71 | - 491.04 | - 640.38 | -15.16 | -51.69 |
| Net earnings | 1 642.26 | 1 692.94 | 2 243.12 | - 762.46 | 594.50 |
Assets (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Development expenditure | 116.13 | 44.35 | 28.96 | 13.57 | |
| Intangible rights | 60.00 | 45.00 | 30.00 | 15.00 | |
| Intangible assets total | 176.13 | 89.36 | 58.96 | 28.57 | |
| Machinery and equipment | 623.94 | 1 237.56 | 526.38 | ||
| Tangible assets total | 623.94 | 1 237.56 | 526.38 | ||
| Holdings in group member companies | 1 134.93 | 1 504.80 | |||
| Investments total | 1 134.93 | 1 504.80 | |||
| Non-current other receivables | 104.30 | 120.62 | 190.41 | 200.53 | 223.97 |
| Long term receivables total | 104.30 | 120.62 | 190.41 | 200.53 | 223.97 |
| Inventories total | |||||
| Current trade debtors | 740.94 | 371.30 | 982.06 | 306.23 | 314.42 |
| Current amounts owed by group member comp. | 2 182.02 | 2 530.63 | 2 424.42 | 501.79 | 2 001.16 |
| Prepayments and accrued income | 115.06 | 239.36 | |||
| Current other receivables | 69.74 | 67.53 | 589.46 | 542.85 | 428.88 |
| Current deferred tax assets | 12.20 | 99.91 | 84.75 | 4.71 | |
| Short term receivables total | 2 992.70 | 3 096.71 | 4 095.85 | 1 674.97 | 2 749.18 |
| Cash and bank deposits | 1 083.50 | 3 345.25 | 6 292.61 | 2 339.45 | 2 440.27 |
| Cash and cash equivalents | 1 083.50 | 3 345.25 | 6 292.61 | 2 339.45 | 2 440.27 |
| Balance sheet total (assets) | 4 980.56 | 7 889.50 | 11 164.22 | 5 378.46 | 6 918.21 |
Equity and liabilities (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 500.00 | 1 500.00 | 2 900.00 | 400.00 | |
| Retained earnings | 698.76 | 841.02 | - 366.03 | 1 877.10 | 714.64 |
| Profit of the financial year | 1 642.26 | 1 692.94 | 2 243.12 | - 762.46 | 594.50 |
| Shareholders equity total | 2 966.03 | 4 158.97 | 4 902.09 | 1 239.64 | 1 834.13 |
| Provisions | 41.33 | ||||
| Non-current deferred tax liabilities | 523.26 | 544.57 | 728.09 | ||
| Non-current liabilities total | 523.26 | 544.57 | 728.09 | ||
| Current trade creditors | 601.72 | 1 280.75 | 3 931.24 | 3 789.22 | 4 993.12 |
| Current owed to participating | 14.45 | ||||
| Current owed to group member | 60.70 | 915.86 | 53.16 | ||
| Short-term deferred tax liabilities | 142.14 | 523.26 | 25.58 | ||
| Other non-interest bearing current liabilities | 645.39 | 1 240.24 | 631.33 | 254.64 | 50.92 |
| Accruals and deferred income | 141.71 | 55.61 | 41.81 | ||
| Current liabilities total | 1 449.94 | 3 185.96 | 5 534.04 | 4 138.82 | 5 084.08 |
| Balance sheet total (liabilities) | 4 980.56 | 7 889.50 | 11 164.22 | 5 378.46 | 6 918.21 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.